TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21410621

Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg/day
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: COMPARATOR
Intervention: Normal androgen sensitivity (≥24 CAG repeats)
Number of subjects: 13
Study: 19302256

Group type: EXPERIMENTAL
Intervention: Skin prick test (SPT)
Number of subjects: 1211
Study: 17298712

Group type: EXPERIMENTAL
Intervention: High monounsaturated fat diet (HMF; 50% fat, 20% protein (67 g/d), 30% carbohydrate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High protein diet (HP; 40% protein (136 g/d), 30% fat, 30% carbohydrate)
Number of subjects: 0
Study: 15145914

Group type: EXPERIMENTAL
Intervention: Older men during isometric contractions
Number of subjects: 18

Group type: COMPARATOR
Intervention: Young men during isometric contractions
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Older men during dynamic contractions
Number of subjects: 18

Group type: COMPARATOR
Intervention: Young men during dynamic contractions
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Preexercise half‐time of tetanic torque relaxation in older men
Number of subjects: 18
Study: 15105231

Group type: EXPERIMENTAL
Intervention: Morphine 100 microg plus clonidine 60-150 microg (MC60-150)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Morphine 100 microg
Number of subjects: 240

Group type: COMPARATOR
Intervention: Clonidine 150 microg
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Morphine 100 microg plus clonidine 30 microg
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Clonidine 60-150 microg (combined group)
Number of subjects: 240
Study: 9892859

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg, mane)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Dothiepin (75 mg rising to 150 mg in the second week, nocte)
Number of subjects: 14
Study: 7503399

Group type: EXPERIMENTAL
Intervention: Specific serum IgE measurement for egg white
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Specific serum IgE measurement for cow's milk
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Specific serum IgE measurement for egg yolk
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Maxisorp RAST using freshly prepared food extracts
Number of subjects: 21

Group type: COMPARATOR
Intervention: DBPCFC (double-blind, placebo-controlled food challenge)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Specific IgE measurements in control subjects tolerant to egg/milk
Number of subjects: 21
Study: 1723772

Group type: EXPERIMENTAL
Intervention: Ro 40-5967 (200 mg)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Ro 40-5967 (100 mg)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Ro 40-5967 (all doses)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Ro 40-5967
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 7178392

Group type: EXPERIMENTAL
Intervention: Short-term psychoeducational group intervention, 'Seminars for the Separated'
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control group (married subjects)
Number of subjects: 237
Study: 31774063

Group type: EXPERIMENTAL
Intervention: Fascial Distortion Model (FDM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Kaltenborn and Evjenth method
Number of subjects: 100
Study: 28369419

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate
Number of subjects: 269

Group type: COMPARATOR
Intervention: Abacavir
Number of subjects: 269
Study: 26133030

Group type: EXPERIMENTAL
Intervention: HPMC (hydroxypropylmethylcellulose)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lactose powder (placebo)
Number of subjects: 40
Study: 23855333

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 21273900

Group type: EXPERIMENTAL
Intervention: 40 mg of triamcinolone acetonide
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 4 ml of 1% procaine HCl
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 40 mg of triamcinolone acetonide and 4 ml of 1% procaine HCl
Number of subjects: 99
Study: 19255204

Group type: EXPERIMENTAL
Intervention: Computer-assisted minimally invasive total knee arthroplasty
Number of subjects: 108

Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty
Number of subjects: 108
Study: 17135285

Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (ERT)
Number of subjects: 0
Study: 15505867

Group type: EXPERIMENTAL
Intervention: Intracoronary radiation therapy with rhenium-188-DTPA-filled balloon
Number of subjects: 161
Study: 11840351

Group type: EXPERIMENTAL
Intervention: Nipradilol
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 7
Study: 9510277

Group type: EXPERIMENTAL
Intervention: Primary Closure (PC)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene Patch Closure (PTFE-P)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Vein Patch Closure (VPC)
Number of subjects: 399
Study: 7802189

Group type: EXPERIMENTAL
Intervention: SMART needle (Doppler ultrasound guided vascular access device)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard technique (blind, external landmark guided technique)
Number of subjects: 40
Study: 29568104

Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 583

Group type: COMPARATOR
Intervention: Low-protein diet
Number of subjects: 583
Study: 26523730

Group type: EXPERIMENTAL
Intervention: Lithium (Li)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Valproic acid (VPA)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Carbamazepine (CBZ)
Number of subjects: 225
Study: 25102297

Group type: EXPERIMENTAL
Intervention: Ultrasonographic (US) guidance during PDT (Group A)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Standard care without image guidance (Group B)
Number of subjects: 341
Study: 23514767

Group type: EXPERIMENTAL
Intervention: Early invitation to food supplementation
Number of subjects: 3267

Group type: EXPERIMENTAL
Intervention: Maternal multiple micronutrient supplementation
Number of subjects: 3267

Group type: EXPERIMENTAL
Intervention: Higher iron supplement
Number of subjects: 3267
Study: 20142600

Group type: EXPERIMENTAL
Intervention: Pre-emptive treatment (skin moisturizers, sunscreen, topical steroid, doxycycline)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Reactive treatment (after skin toxicity developed)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Pre-emptive treatment
Number of subjects: 95

Group type: COMPARATOR
Intervention: Reactive treatment
Number of subjects: 95
Study: 19198140

Group type: EXPERIMENTAL
Intervention: Zonisamide
Number of subjects: 0
Study: 16573295

Group type: EXPERIMENTAL
Intervention: Rate control
Number of subjects: 4060

Group type: COMPARATOR
Intervention: Rhythm control
Number of subjects: 4060

Group type: EXPERIMENTAL
Intervention: Event-free survival
Number of subjects: 4060
Study: 14523461

Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 55

Group type: COMPARATOR
Intervention: IFN+AraC
Number of subjects: 55
Study: 10739327

Group type: EXPERIMENTAL
Intervention: Olanzapine (5 to 20 mg/day)
Number of subjects: 1714

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 1714
Study: 9359973

Group type: EXPERIMENTAL
Intervention: human corticotropin-releasing hormone (hCRH)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 10
Study: 1470719

Group type: EXPERIMENTAL
Intervention: Intermittent rest of respiratory muscles through a negative pressure external respirator (shield type) for three consecutive days
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (Group II)
Number of subjects: 34
Study: 3548982

Group type: EXPERIMENTAL
Intervention: Diflunisal (500 mg BID, increased to 750 mg BID for non-responders)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Naproxen (375 mg BID, increased to 500 mg BID for non-responders)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Diflunisal (safety assessment)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Naproxen (safety assessment)
Number of subjects: 31
Study: 31423703

Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 132

Group type: COMPARATOR
Intervention: Enseal
Number of subjects: 132
Study: 29907624

Group type: EXPERIMENTAL
Intervention: Rectal douching/enema (RD) performed weekly or more
Number of subjects: 395

Group type: COMPARATOR
Intervention: Not douching
Number of subjects: 395
Study: 27383498

Group type: EXPERIMENTAL
Intervention: Real-time tele-transmission system of 12-lead electrocardiogram (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 60
Study: 24356253

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) pediatric tablets (100/25 mg) administered twice daily according to FDA weight bands
Number of subjects: 53

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/r) pediatric tablets (100/25 mg) administered once daily according to FDA weight bands
Number of subjects: 53
Study: 21681387

Group type: EXPERIMENTAL
Intervention: Self-adhesive resin cement (RelyX Unicem Aplicap, 3M ESPE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Zinc oxide phosphate cement (Hoffmann's Cement, Hoffmann)
Number of subjects: 20
Study: 20074698

Group type: EXPERIMENTAL
Intervention: Internal drainage
Number of subjects: 100

Group type: COMPARATOR
Intervention: External drainage
Number of subjects: 100
Study: 18042975

Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Nebulized ipratropium bromide
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Bronchodilator groups (salbutamol and ipratropium)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 15653705

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 30 mg kg(‐1) as a bolus before induction and 10 mg kg(‐1) h(‐1) by infusion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clonidine 3 microg kg(‐1) as a bolus before induction and 2 microg kg(‐1) h(‐1) by infusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (isotonic solution)
Number of subjects: 60
Study: 12375321

Group type: EXPERIMENTAL
Intervention: Culturally sensitive cholesterol lowering diet program
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 17
Study: 10434229

Group type: EXPERIMENTAL
Intervention: 5 mg chewable tablet of montelukast
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10 mg film-coated tablet of montelukast (adults)
Number of subjects: 0
Study: 7788204

Group type: EXPERIMENTAL
Intervention: Fenoterol inhaled 10 min before induction
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo inhaled 10 min before induction
Number of subjects: 50
Study: 2112150

Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRH‐a) leuprolide acetate depot
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Progesterone supplementation in vitro
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Estrogen in vitro
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: GnRH‐a in vitro
Number of subjects: 17
Study: 472679

Group type: EXPERIMENTAL
Intervention: Björk-Shiley valve
Number of subjects: 35

Group type: COMPARATOR
Intervention: Lillehei-Kaster valve
Number of subjects: 35
Study: 31386826

Group type: EXPERIMENTAL
Intervention: Dietary advice and HIIT (n = 22)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Dietary advice only (n = 22)
Number of subjects: 44
Study: 30445547

Group type: EXPERIMENTAL
Intervention: Attention to BMI Alone
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Attention to BMI/Medical Risk
Number of subjects: 308

Group type: COMPARATOR
Intervention: No Attention
Number of subjects: 308
Study: 28185643

Group type: EXPERIMENTAL
Intervention: Oral triiodothyronine (T3; 1 μg/kg per body weight/dose) administered every 6 hours for 60 hours after induction of anesthesia
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Oral triiodothyronine (T3)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo (saccharum lactis)
Number of subjects: 205
Study: 25591992

Group type: EXPERIMENTAL
Intervention: Avanafil 100 mg
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Avanafil 200 mg
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440
Study: 24378658

Group type: EXPERIMENTAL
Intervention: E-R (Endurance before Resistance)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: R-E (Resistance before Endurance)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 23
Study: 22775479

Group type: EXPERIMENTAL
Intervention: Topical Xilei San (0.1 g/dose per day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Topical Xilei San
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 19541567

Group type: EXPERIMENTAL
Intervention: Chest vibration nursing intervention (mechanical chest wall vibration pad for 60 minutes, 6 times a day for 72 hours)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Chest vibration nursing intervention
Number of subjects: 95

Group type: COMPARATOR
Intervention: Routine positioning care (control group, change in body position every 2 hours)
Number of subjects: 95
Study: 17700222

Group type: EXPERIMENTAL
Intervention: Fluvastatin (40 mg/day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 15831796

Group type: EXPERIMENTAL
Intervention: High-glycemic index (HGI) carbohydrate breakfast (2.5g CHO/kg body mass)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Low-glycemic index (LGI) carbohydrate breakfast (2.5g CHO/kg body mass)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High-glycemic index (HGI) carbohydrate breakfast
Number of subjects: 7

Group type: COMPARATOR
Intervention: Low-glycemic index (LGI) carbohydrate breakfast
Number of subjects: 7
Study: 11953077

Group type: EXPERIMENTAL
Intervention: Nitroglycerin patch
Number of subjects: 60

Group type: COMPARATOR
Intervention: Magnesium sulfate and salbutamol sulfate
Number of subjects: 60
Study: 9798803

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg o.d.
Number of subjects: 248

Group type: COMPARATOR
Intervention: Omeprazole 20 mg o.d.
Number of subjects: 248
Study: 7706102

Group type: EXPERIMENTAL
Intervention: Synchronized intermittent mandatory ventilation (SIMV) with 10 cm H2O pressure support
Number of subjects: 10

Group type: COMPARATOR
Intervention: Assist-control
Number of subjects: 10

Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation (SIMV)
Number of subjects: 10

Group type: COMPARATOR
Intervention: All three modes of mechanical ventilation
Number of subjects: 10
Study: 2132303

Group type: EXPERIMENTAL
Intervention: Orchiectomy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Polyoestradiol phosphate (PEP) 160 mg/month i.m.
Number of subjects: 200
Study: 453276

Group type: EXPERIMENTAL
Intervention: Electronic fetal monitoring alone
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Electronic monitoring with the option to scalp sample
Number of subjects: 690

Group type: COMPARATOR
Intervention: Auscultation
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: All groups (auscultation, electronic fetal monitoring alone, electronic monitoring with scalp sample)
Number of subjects: 690
Study: 31915308

Group type: EXPERIMENTAL
Intervention: Mirtazapine (dose not specified) over 28 days
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 30219327

Group type: EXPERIMENTAL
Intervention: CTO PCI
Number of subjects: 205

Group type: COMPARATOR
Intervention: No CTO PCI
Number of subjects: 205
Study: 25424132

Group type: EXPERIMENTAL
Intervention: Supervised implementation of an oral healthcare protocol and education
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 23978872

Group type: EXPERIMENTAL
Intervention: 450 mg/day UDCA
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 22264193

Group type: EXPERIMENTAL
Intervention: Playing a first-person shooter video game for a cumulative total of 10 hours
Number of subjects: 25
Study: 19710354

Group type: EXPERIMENTAL
Intervention: Guided Care (GC)
Number of subjects: 196
Study: 18346976

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg) treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Prednisolone and NSAIDs (Control)
Number of subjects: 12
Study: 16163627

Group type: EXPERIMENTAL
Intervention: Famciclovir 125 mg twice daily for 5 days
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Famciclovir 250 mg twice daily for 5 days
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Famciclovir 500 mg twice daily for 5 days
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Famciclovir (all doses)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study: 12188088

Group type: EXPERIMENTAL
Intervention: Intact bovine colostrum protein powder (60 g x day(‐1))
Number of subjects: 30

Group type: COMPARATOR
Intervention: Concentrated whey protein powder placebo
Number of subjects: 30
Study: 10815307

Group type: EXPERIMENTAL
Intervention: Calcium alginate
Number of subjects: 30

Group type: COMPARATOR
Intervention: Silicone-coated polyamide net dressing
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 8979563

Group type: EXPERIMENTAL
Intervention: Phenobarbitone (PB)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Sodium Valproate (SVP)
Number of subjects: 151

Group type: COMPARATOR
Intervention: All three drugs (PB, PHT, SVP)
Number of subjects: 151
Study: 2061417

Group type: EXPERIMENTAL
Intervention: 0.5% metronidazole
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 6150121

Group type: EXPERIMENTAL
Intervention: Activated charcoal, 50 g, given 5 min after 400 mg cimetidine + 10 mg pindolol
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Syrup of ipecac
Number of subjects: 7
Study: 30590425

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 21104

Group type: EXPERIMENTAL
Intervention: Higher dose edoxaban
Number of subjects: 21104

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 21104
Study: 29462506

Group type: EXPERIMENTAL
Intervention: LCPT (extended-release tacrolimus tablets)
Number of subjects: 0
Study: 27244765

Group type: EXPERIMENTAL
Intervention: Triptorelin 0.1 mg (Group A)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Triptorelin 50 µg (Group B)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Triptorelin 25 µg (Group C)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Group A
Number of subjects: 91

Group type: COMPARATOR
Intervention: Group B
Number of subjects: 91

Group type: COMPARATOR
Intervention: Group C
Number of subjects: 91
Study: 25755182

Group type: EXPERIMENTAL
Intervention: Thigh intermuscular fat (per SD increment) in men
Number of subjects: 5187

Group type: EXPERIMENTAL
Intervention: Visceral fat (per SD increment) in women
Number of subjects: 5187

Group type: EXPERIMENTAL
Intervention: Abdominal subcutaneous fat (per SD increment) in women
Number of subjects: 5187
Study: 21929830

Group type: EXPERIMENTAL
Intervention: 1-session CBT-based panic management intervention (PMI)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 7-session CBT intervention
Number of subjects: 58

Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 58
Study: 20337206

Group type: EXPERIMENTAL
Intervention: Letrozole (5 mg daily from day 3-7 of menstrual cycle)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Clomiphene citrate (100 mg daily from day 3-7 of menstrual cycle)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Letrozole (5 mg daily)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Clomiphene citrate (100 mg daily)
Number of subjects: 107
Study: 18765955

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 2448

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2448
Study: 15671186

Group type: EXPERIMENTAL
Intervention: Depression care management intervention over 24 months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study: 11792152

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (600 mg/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ibuprofen (600 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 10414474

Group type: EXPERIMENTAL
Intervention: Education/behavior modification classes for 6 months
Number of subjects: 38

Group type: COMPARATOR
Intervention: Usual office visits (Control)
Number of subjects: 38
Study: 7730962

Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer dentifrice (0.3% triclosan and 2.0% copolymer)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Customary oral hygiene care
Number of subjects: 124
Study: 2341773

Group type: EXPERIMENTAL
Intervention: Titanium grommets
Number of subjects: 31

Group type: COMPARATOR
Intervention: Shepard design Teflon grommet
Number of subjects: 31
Study: 6313820

Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 30920129

Group type: EXPERIMENTAL
Intervention: Good social support from family and friends
Number of subjects: 1294

Group type: EXPERIMENTAL
Intervention: Age 70–79 years
Number of subjects: 1294

Group type: EXPERIMENTAL
Intervention: Age >80 years
Number of subjects: 1294

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 1294

Group type: EXPERIMENTAL
Intervention: Non-Malay
Number of subjects: 1294

Group type: EXPERIMENTAL
Intervention: Received only informal education
Number of subjects: 1294

Group type: EXPERIMENTAL
Intervention: Had gastritis
Number of subjects: 1294

Group type: EXPERIMENTAL
Intervention: Had a stroke
Number of subjects: 1294

Group type: EXPERIMENTAL
Intervention: Perceived current health status as satisfactory
Number of subjects: 1294

Group type: EXPERIMENTAL
Intervention: Disabled based on WHO Disability Assessment Schedule
Number of subjects: 1294